[go: up one dir, main page]

CN111876423A - Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative - Google Patents

Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative Download PDF

Info

Publication number
CN111876423A
CN111876423A CN202010777466.8A CN202010777466A CN111876423A CN 111876423 A CN111876423 A CN 111876423A CN 202010777466 A CN202010777466 A CN 202010777466A CN 111876423 A CN111876423 A CN 111876423A
Authority
CN
China
Prior art keywords
aptamer
nitrobenzene
derivative
nucleic acid
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010777466.8A
Other languages
Chinese (zh)
Other versions
CN111876423B (en
Inventor
谢丹平
贾文超
胡克梅
刘莹
刘丽君
丁紫荣
付建平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Institute of Environmental Science of Ministry of Ecology and Environment
Original Assignee
South China Institute of Environmental Science of Ministry of Ecology and Environment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Institute of Environmental Science of Ministry of Ecology and Environment filed Critical South China Institute of Environmental Science of Ministry of Ecology and Environment
Priority to CN202010777466.8A priority Critical patent/CN111876423B/en
Publication of CN111876423A publication Critical patent/CN111876423A/en
Application granted granted Critical
Publication of CN111876423B publication Critical patent/CN111876423B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/315Phosphorothioates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/31Chemical structure of the backbone
    • C12N2310/318Chemical structure of the backbone where the PO2 is completely replaced, e.g. MMI or formacetal
    • C12N2310/3181Peptide nucleic acid, PNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/323Chemical structure of the sugar modified ring structure
    • C12N2310/3231Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a nitrobenzene aptamer, a nitrobenzene aptamer derivative and application thereof, wherein the sequence of the nitrobenzene aptamer is a DNA fragment shown as the following. The aptamer can be various similar sequences with higher homology or derivatives obtained by the sequence of the invention. The aptamer and the derivative thereof can be used for detecting, separating, purifying and other products of environmental, food and biological harmful factors, preparing nitrobenzene detection probes and the like. Has the advantages of high specificity and high affinity with nitrobenzene, chemical synthesis, stable property, small molecular weight, good biocompatibility, easy storage and the like.

Description

Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative
Technical Field
The invention relates to a nucleic acid aptamer, a nucleic acid aptamer derivative and application thereof, in particular to a nucleic acid aptamer capable of being combined with nitrobenzene, a nucleic acid aptamer derivative and application thereof.
Background
Nitrobenzene (NB) is an important raw material for the production of aniline, and its residues are discharged into water with waste during the production process. The benzene ring in the chemical structure of the composite material is stable and difficult to degrade, has a density higher than that of water, is easy to deposit in the water body, and causes pollution to the water body. NB belongs to a highly toxic pollutant, and can invade into the human body through respiratory tract, digestive tract, skin, oral cavity and other modes, causing damage to human blood, liver and central nervous system, so the us national environmental protection agency lists it as one of 128 types of 'priority control toxic organic pollutants'. Therefore, it is important to enhance the analysis and detection of nitrobenzene compounds in water. The state has strict regulations on the discharge of nitrobenzene from water. At present, a chromatography-mass spectrometry and combined detection mode are commonly used in a detection method of nitrobenzene compounds in water, so that the operation is complex and long in time consumption, a large amount of organic solvents are used in the using process, and meanwhile, the treatment cost of organic waste liquid and environmental pollution are increased. Therefore, it has become a great demand to be able to perform green, fast, and efficient detection of nitrobenzene in water.
Aptamers, which are single-stranded DNA or RNA molecules artificially synthesized from bases and having high-specificity and high-affinity recognition ability of antibodies to various types of substances (e.g., ions, small molecules, proteins, bacteria, etc.), are called chemical antibodies. The preparation process of the aptamer is generated by Exponential Enrichment system Evolution (SELEX), and the system is characterized in that a single-stranded random oligonucleotide library is constructed in vitro by combining synthetic chemistry and molecular biology technologies, and the target aptamer capable of being identified with a target is finally obtained through multiple screening and Exponential Enrichment. The method comprises the following specific steps: first, a synthetic resin containing 1012~1015The DNA/RNA oligonucleotide random library has sequence length of 70-100 bases, random sequence in the middle and fixed sequences at two ends. By mixingSeparating the nucleic acid combined with the target from the invalid nucleic acid chain, simultaneously carrying out PCR amplification on the retained nucleic acid molecules, obtaining a library with affinity to the target after multiple screening and PCR amplification, and finally carrying out sequencing analysis to obtain fragment information of the nucleic acid in the library. Compared with the antibody, the preparation period is short, the success rate is high, the storage period is longer, the property is more stable, and large-scale chemical synthesis, modification and marking can be carried out, so that the surface of the sensor is easy to be fixed and modified, the antibody is suitable for being combined with nano, fluorescent and other materials, and the problem of rapid development of the recognition molecule can be solved.
Although the aptamers have the above-mentioned advantages, in particular, for a substance such as nitrobenzene, the aptamers are not always available by performing the above-mentioned procedures, and high-quality aptamers for some substances are extremely difficult to obtain. This is because, compared with small-molecule compounds having a large molecular weight and rich chemical functional groups, nitrobenzene has a weak recognition force when interacting with a nucleic acid library, and thus it is very difficult to obtain an aptamer having high affinity for nitrobenzene.
A large number of researchers have not found aptamers with high affinity to nitrobenzene and low cost for many years. If a nitrobenzene nucleic acid aptamer is obtained, a new means for detecting nitrobenzene and an expanded application range are expected to be provided.
Disclosure of Invention
The technical problem to be solved by the invention is to overcome the defects of the prior art and provide a nitrobenzene aptamer, a nitrobenzene aptamer derivative and application thereof, wherein the nitrobenzene aptamer, the nitrobenzene aptamer derivative and the nitrobenzene aptamer derivative can be combined with nitrobenzene in high specificity and high affinity, can be chemically synthesized, and have good biocompatibility, small molecular weight, stability and easy storage.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
the aptamer of nitrobenzene is characterized in that the nucleotide sequence of the aptamer is shown as SEQ ID No.1 or 2 in a sequence table.
Further, a position on the nucleotide sequence of the aptamer is phosphorylated, oxymethylated, methylated, aminated, thiolated, fluorinated, or isotopically esterified.
Furthermore, biotin, digoxin, fluorescent substances, nano materials, polyethylene glycol, peptide fragments, proteins, enzymes or folic acid labels are combined on the nucleotide sequence of the aptamer.
The invention also provides a nucleic acid aptamer derivative of nitrobenzene, which is characterized in that the nucleic acid aptamer derivative is a phosphorothioate skeleton derived from the skeleton of the nucleotide sequence of the nucleic acid aptamer, or is corresponding locked nucleic acid or peptide nucleic acid modified by the nucleic acid aptamer.
The invention also provides application of the aptamer or the aptamer derivative, which is characterized in that the aptamer or the aptamer derivative is used for detecting nitrobenzene in environment, food and organisms.
The invention also provides an application of the aptamer or the aptamer derivative, which is characterized in that nitrobenzene is separated and purified by using the aptamer or the aptamer derivative.
The invention also provides application of the aptamer or the aptamer derivative, which is characterized in that the aptamer or the aptamer derivative is used for preparing a nitrobenzene detection probe.
In another aspect, the present invention provides a nitrobenzene detection method, which is characterized by comprising the following steps:
step (1), preparing the aptamer or the aptamer derivative;
step (2), preparing a detection probe of the nitrobenzene nucleic acid aptamer;
step (3) immobilizing the detection probe on the surface of the SPR chip, wherein the detection probe is immobilized by bovine serum albumin
Sealing the chip of the detection probe;
and (4) carrying out nitrobenzene determination by using the chip on which the detection probe is immobilized.
The nucleotide sequences, whether partially substituted or modified, all have the same or similar molecular structure, physicochemical properties and functions as the original aptamer, and can be used for specific binding with nitrobenzene.
Compared with the prior art, the invention has the advantages that:
(1) the nucleic acid aptamer can be combined with nitrobenzene with high affinity and high specificity, has the advantages of good stability, no toxicity, easy modification and the like, and is beneficial to large-scale industrial production and application.
(2) The nucleic acid aptamer has the characteristic of easy modification, and can convert ultraviolet absorption signals of nitrobenzene into other signals (such as fluorescence) by modifying signal substances, so that high-sensitivity detection of the nitrobenzene is realized.
Drawings
FIG. 1 shows the result of the determination of the affinity between a aptamer probe and nitrobenzene in the examples of the present invention.
FIG. 2 shows the result of the measurement of the specificity of the aptamer probe for nitrobenzene in the examples of the present invention.
FIG. 3 shows the SPR measurement of nitrobenzene using aptamer probe in the present invention.
FIG. 4 shows the result of unlabeled fluorescence detection of aptamer p-nitrobenzene in the examples of the present invention.
FIG. 5 shows fluorescence polarization detection results of aptamer p-nitrobenzene in the examples of the present invention.
Detailed Description
The invention is further described below with reference to the drawings and specific preferred embodiments, without thereby limiting the scope of protection of the invention.
Example (b):
the nucleotide sequence of the aptamer of nitrobenzene of the invention comprises a DNA fragment shown as the following sequence, which can be specifically combined with nitrobenzene:
5’-CACGCATAGGCTCGCCGTAACACACCACACATAGGTCCGCTATTCGCGTCCCTATGCGTG-3’
the nucleotide sequence of the aptamer is selected from naturally occurring or artificially synthesized sequences, or any other source of the same.
It is noted that the scope of the present invention encompasses all sequences comprising the aptamer.
The present invention encompasses such sequences that are phosphorylated, hypermethylated, methylated, fluorinated, aminated, thiolated, or isotopically-modified at a position on the nucleotide sequence of the aptamer.
The invention covers the sequence of the nucleic acid aptamer combined with biotin, digoxigenin, fluorescent substance, nano material, polyethylene glycol, peptide fragment, protein, enzyme or folic acid label (even with radioactive substance connected).
The aptamer can derive other aptamers, and the nucleotide sequence of the derived aptamer can be any one of the following three sequences:
(1) the homology with the nucleotide sequence of the aptamer listed in the embodiment is more than 90% (for example, the nucleotide sequence of the aptamer can be partially complementary by deletion or addition);
(2) a sequence that hybridizes to the nucleotide sequence of the aptamer listed in this example;
(3) this example embodies the RNA sequences transcribed from the nucleotide sequences of the listed aptamers.
The backbone of the nucleotide sequence of the aptamers listed in this example may also be derivatized to a phosphorothioate backbone, and the aptamers described above may also be engineered to lock nucleic acids or peptide nucleic acids accordingly.
The aptamer for nitrobenzene of the present example has the following uses: the application in detecting harmful factors of environment, food and organisms; ② separating and purifying; the usage in the design and development of the medicine; and fourthly, preparing the nitrobenzene detection probe.
The nitrobenzene CAS number used in this example is: 98-95-3.
The aptamer of nitrobenzene in the embodiment is mainly screened by a magnetic bead capture method, and the specific screening process comprises the following steps:
(a) optimizing the nucleic acid library: the structure of the DNA library is divided into three parts. The middle is a random sequence of 40 bases; the random sequence is flanked by two DNA arms, sequences necessary for PCR amplification of 20 fixed bases, while the fixed sequence at the 5' end is complementarily hybridized to the immobilized probe (BDNA). The immobilized probe is a DNA strand which is labeled with biotin at one end and is complementary to the immobilized sequence of the library, and is used for immobilizing the library.
Random library Lib:
5 '-ATTGGCACTCCACGCATAGGNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCTATGCGTGCTACCGTGAA-3' (note: N represents any one of A, T, C, G bases);
5' primer: 5'-ATTGGCACTCCACGCATAGG-3', respectively;
3' primer: 5'-TTCACGGTAGCACGCATAGG-3', respectively;
5' fluorescent primer: 5 '-FAM-ATTGGCACTCCACGCATAGG-3';
3' spacer primer: 5'-AAAAAAAAAAAAAAAAAAAAAAAAA-spacer18-TTCACGGTAGCACGCATAGG-3'
BDNA immobilized probe: 5'-CCTATGCGTGGAGTGCCAAT-biotin-3'
(b) Primary screening: library pre-treatment method: 1.3nmol of the library (about 10)14DNA strand), 2.9nmol BDNA in 289. mu.L DPBS buffer (0.9mmol/L CaCl)2、2.7mmol/L KCl、1.5mmol/L KH2PO4、0.5mmol/LMgCl2、136.9mmol/L NaCl、8.1mmol/L Na2HPO4) Pre-denaturing at 95 deg.c for 10min, cooling to 60 deg.c at 0.1 deg.c/sec for 1min, and cooling to 25 deg.c at 0.1 deg.c/sec for slow renaturation. The hybridization library was added to a 1mL amount of streptavidin-labeled magnetic bead particles that had been washed 5 times and incubated at room temperature for half an hour in a shaker. The beads were then adsorbed using a magnet and the supernatant was removed, and the beads were suspended and washed 6 times with 400. mu.L of DPBS buffer. The nitrobenzene target solution was then added and placed in a shaker for 40min incubation at room temperature. Adsorbing the magnetic beads with a magnet, and recovering the supernatant to obtain a preliminary screening nucleic acid library containingThere is a complex of DNA and nitrobenzene.
(c) And (3) purification: and (c) carrying out PCR amplification on the primary screening nucleic acid library obtained in the step (b), wherein the amplification primers adopt the primers with the 5 'end and the 3' end which are listed in the step (a) and provided with the spacer arms. And performing single-strand preparative separation on the amplification product by using SDS (sodium dodecyl sulfate) denaturing PAGE (polyacrylamide gel electrophoresis), and then boiling, concentrating by using n-butanol and dialyzing to form a secondary nucleic acid library. Wherein, the PCR reaction amplification conditions are as follows: denaturation at 95 ℃ for 30s, annealing at 60 ℃ for 30s, extension at 72 ℃ for 30s, and amplification of N (optimal number of rounds) for several cycles; extension at 72 ℃ for 7 min. And (3) optimizing the annealing temperature by adopting gradient PCR and taking the initial nucleic acid library as a template, wherein the final obtained annealing temperature is 60 ℃. And the optimal number of amplification rounds of each round of screening products is obtained through round number optimization. After round number optimization, the remaining libraries were amplified under the same conditions. Preparing single strand from the PCR later library for the next round of screening, wherein the single strand preparation method comprises the following steps: mixing the PCR product with n-butanol according to the volume ratio of 1: 5 mixing, shaking and mixing for 30s, centrifuging at 6000rpm for 15s, allowing the solution to stratify, removing the upper n-butanol liquid, retaining the lower solution, and allowing the lower solution to be about 50 μ L in volume, adding an equal volume of 2 × TBE solution to the solution, and heating at 95 deg.C for 10 min. The samples were loaded on denaturing gel PAGE while hot, run for 20min using 300V voltage, cut off and collect the fluorescent bands under UV irradiation, and break the gel. Adding 1.2mL of DPBS buffer solution into the crushed gel, boiling for 15min at 95 ℃, centrifuging, collecting supernatant, and repeating for 1-2 times. Adding a mixture of the following components in a volume ratio of 1: 5, shaking for 30s, centrifuging at 6000rpm for 3min, and removing the upper n-butanol layer. Repeating for 2-3 times to make the final sample volume be about 100 μ L. Finally, the samples were dialyzed in DPBS solution overnight at 4 ℃ in a refrigerator.
(d) And (3) circulation: replacing the initial nucleic acid library with the secondary nucleic acid library obtained above and repeating the above steps (b) to (c), using new streptavidin-coated magnetic beads for each cycle, until a nucleic acid library comprising aptamers that bind with high affinity and high specificity to nitrobenzene is obtained.
(e) Evaluation of screening efficiency: screening efficiency was determined by qPCR, i.e.screenedEnrichment of DNA in the process. The detection signal is C of the DNA library in the qPCR processqValues, converted to the retention of the nitrobenzene pair library. First, a series of concentrations of nucleic acid library solutions were prepared and measured using qPCR, yielding a linear equation of concentration versus Cq value. Then, the concentration of the DNA library in which nitrobenzene competes out is determined again, and the library retention is obtained from the ratio of the measured amount to the input amount. The higher the screening efficiency, the higher the retention. When the retention rate reached plateau, the library was subjected to clonal sequencing.
Investigation 1: the affinity between nitrobenzene and its aptamer in this example is mainly determined by Surface Plasmon Resonance (SPR) method, and the specific determination process includes the following steps:
(1) design of the Probe
5' end of nitrobenzene nucleic acid aptamer is marked with NH2Group (sensing probe 1):
5'-NH2-CACGCATAGGCTCGCCGTAACACACCACACATAGGTCCGCTATTCGCGTCCCTATGCGTG-3'
(1) immobilization of aptamer on SPR sensing chip surface
The sensor probe 1 is fixed on the surface of the SPR chip by using an amino coupling mode: a mixed solution of 0.4M (1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride) EDC and 0.1M NHS (N-hydroxysuccinimide) at the final concentration was continuously reacted and activated for 7min on a sensor chip model CM5 of BIAcore, then a sensor probe 1 labeled with an amino group was introduced at a concentration of 50. mu.M and continuously reacted for 10min, and finally the chip was blocked for 30s using ethanolamine at a concentration of 1M.
(2) Determination of affinity: target nitrobenzene (50nmol/L, 100nmol/L, 200nmol/L, 400nmol/L, 800nmol/L, 1600nmol/L) at different concentrations was added to the flow cell, incubated with the DNA modified on the gold membrane for 3min, washed with binding buffer for 1.5min, and the sensing curve was recorded in real time, as shown in FIG. 1 (A). As shown in FIG. 1(B), the dissociation constant (K) between the probe and nitrobenzene was calculated by plotting the concentration of the target as the abscissa and the response signal caused by the binding of the target to DNA at different concentrations as the ordinatedValue), measuring K of the probedThe value was 167. + -.8 nM. The affinity between small molecule compounds and nucleic acids ranges from 100nM to 50. mu.M, and the affinity between most small molecules and their aptamers ranges from. mu.M. It is demonstrated that the nitrobenzene nucleic acid aptamers we screened were at high affinity levels.
Investigation 2: the specificity between nitrobenzene and its aptamer of this example was mainly determined by fluorescence recovery, and the specific determination procedure included the following steps:
(1) design of the Probe
The 3' -end of the nitrobenzene nucleic acid aptamer is labeled with Cy3 fluorescent dye (aptamer fluorescent probe 1):
5'-CACGCATAGGCTCGCCGTAACACACCACACATAGGTCCGCTATTCGCGTCCCTATGCGTG-Cy3-3';
the 5' end of the aptamer complementary sequence was labeled with a BHQ-2 fluorescence quenching group (quenching probe):
5'-BHQ-2-CACGCATAGGGACGCGAATAGCGGACCTATGTGTGGTGTGTTACGGCGAGCCTATGCGTG-3';
(2) determination of specificity: and (3) respectively preparing solutions of the aptamer fluorescent probe and the quenching probe with the concentration of 2 mu M by taking DPBS as a solvent, transferring 75 mu L of solution into each solution, mixing the solutions, shaking and uniformly mixing the solutions, and incubating for 30min at room temperature for later use. The mixed solution was equally divided into three equal parts (50. mu.L each), 50. mu.L of a nitrobenzene solution (nitrobenzene) having a concentration of 2. mu.M, 50. mu.L of an aniline solution (Negative control) having a concentration of 6. mu.M, and 50. mu.L of a screening buffer solution (Blank control) were added to the three parts, and reacted at room temperature for 10min, and then the solutions were transferred to 96-well plates and scanned for fluorescence emission spectra using a multifunction scanner, and fluorescence emission spectra of the above 3 reaction solutions were obtained. As can be seen from fig. 2, for aniline at a concentration 3 times that of nitrobenzene, nitrobenzene produces fluorescence at an intensity of about 42500a.u., whereas aniline at about 7300a.u., the ratio of response values is about 6 times. The aptamer probe is proved to have higher reaction specificity on nitrobenzene, and the aptamer provided by the patent can recognize nitrobenzene with higher specificity.
Investigation 3: the method for measuring nitrobenzene by adopting an SPR sensing competition method comprises the following steps:
detection probe for nitrobenzene nucleic acid aptamer 1:
5’-biotin-CACGCATAGGCTCGCCGTAACACACCACACATAGGTCCGCTATTCGCGTCCCTATGCGTG-3’;
(1) immobilization of nitrobenzene-bovine serum albumin complex on surface of CM5 sensor chip
The sensing probe 1 is fixed on the surface of the SPR chip by means of amino coupling: a mixed solution of 0.4M (1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride) EDC and 0.1M NHS (N-hydroxysuccinimide) at the final concentration was continuously reacted and activated for 7min on a sensor chip model CM5 of BIAcore, then a solution of a nitrobenzene-bovine serum albumin complex at a concentration of 10. mu.g/mL was introduced and continuously reacted for 3min, and finally the chip was blocked with bovine serum albumin at a concentration of 1mg/mL for 1 min.
(2) Determination of nitrobenzene by SPR competition method
The detection probe 1 and streptavidin (streptavidin, SA) solution are mixed according to a molar ratio of 4: 1 for 30min, the final concentration of the product was 30. mu.M. Different concentrations of target nitrobenzene (10.188nmol/L, 20.375nmol/L, 40.750nmol/L, 81.500nmol/L, 163.00nmol/L, 326.00nmol/L, 652.00nmol/L, 1250.0nmol/L, 2500.0nmol/L, 5000.0nmol/L, 10000nmol/L) were mixed with the product prepared above in a volume ratio of 1: 1 to form 200 mu L of mixed solution, adding the mixed solution into a flow cell respectively, incubating the mixed solution with nitrobenzene-bovine serum albumin modified on a gold membrane for 3min, washing the mixed solution for 1.5min by using a binding buffer solution, and recording a curve. The logarithm of the concentration of the target was plotted as the abscissa and the response signal caused by binding of different concentrations of the target was plotted as the ordinate (see FIG. 3B). It can be seen that as the concentration of nitrobenzene increases, the response value gradually decreases, and a certain inhibition relationship is presented.
Consider 4: the nitrobenzene is measured by a label-free fluorescence method, and the specific measurement process comprises the following steps:
the concentration of the immobilized aptamer was 2. mu.M, and an equal volume of 2 XEventreen dye was added thereto and shaken to form 300. mu.L of a mixed solution. Heating the mixed solution at 95 ℃ for 10min, cooling to room temperature, and adding 50 mu L nitrobenzene solution with final concentration of 195ppb, 390ppb, 781ppb, 1562ppb, 3125ppb, 12500ppb and 25000 ppb. As shown in FIG. 4, it can be seen from the fluorescence emission spectrum result that the fluorescence signal gradually decreases with the increase of the concentration of nitrobenzene, and a good linear relationship is shown between the fluorescence signal and the logarithm of the concentration of nitrobenzene.
Review 5: the nitrobenzene is measured by adopting a fluorescence polarization technology, and the specific measurement process comprises the following steps:
(1) hybrid sequence 1:
5’-SH-AAAAAAAAAACACGCATAGGGACGCGAATAGCGGACCTATGTGTGGTGTGTTACGGCGAGCCTATGCGTG-3’;
the hybridization sequence 2:
5’-SH-AAAAAAAAAACCCCCCCCCCAAAAAACCCCCCCCCCCCCAAAAAAGGGAAAGGAAAACCCCCACCCCCC-3’。
(2) aptamer fluorescent probe 2:
5’-CACGCATAGGCTCGCCGTAACACACCACACATAGGTCCGCTATTCGCGTCCCTATGCGTG-FAM-3’;
DNA control fluorescent probe:
5’-GGGGGGTGGGGGTTTTCCTTTCCCTTTTTTGGGGGGGGGGGGGTTTTTTGGGGGGGGGG-FAM-3’。
preparing a nano silver aptamer fluorescent probe and a DNA contrast probe: (a) the decahedral nano silver is selected as a nano material, 1mL decahedral nano silver solution is transferred, 100 muL of hybridization sequence 1 solution with the concentration of 10 muM and 64 muL of 2M sodium chloride solution are added into the decahedral nano silver solution, the mixture is uniformly shaken and mixed, and the mixture is shaken and reacted for 30min at room temperature and then kept overnight for later use. Centrifuging the prepared nano silver solution at 15000rpm for 10min, removing supernatant, adding 1mL screening buffer, centrifuging at 15000rpm for 10min, removing supernatant, and repeating for 3 times. Then, 100. mu.L of a 100. mu.M fluorescent probe 2 solution was added thereto, and the reaction was carried out at room temperature for 30 min. Then centrifuged, the supernatant removed and resuspended in 500. mu.L of selection buffer for use. (b) And similarly, using decahedral nano silver as a nano material, transferring 1mL decahedral nano silver solution, adding 100 mu L of hybridization sequence 2 solution with the concentration of 10 mu M and 64 mu L of 2M sodium chloride solution, shaking and mixing uniformly, shaking and reacting at room temperature for 30min, and standing overnight for later use. Centrifuging the prepared nano silver solution at 15000rpm for 10min, removing supernatant, adding 1mL screening buffer, centrifuging at 15000rpm for 10min, removing supernatant, and repeating for 3 times. Then, 100. mu.L of a solution of aptamer fluorescent probe 3 at a concentration of 100. mu.M was added thereto, and the reaction was carried out at room temperature for 30 min. Then centrifuged, the supernatant removed and resuspended in 500. mu.L of selection buffer for use.
The nano-silver aptamer fluorescent probe and the DNA contrast probe solution are equally divided into 5 equal parts respectively, the 5 equal parts are added into a 96-well plate, 100 mu L nitrobenzene solution with the final concentration of 40nM, 160nM, 640nM, 2560nM and 10240nM is added respectively, the reaction is carried out for 10min at room temperature, and then the fluorescence polarization detection analysis is carried out. As can be seen from fig. 5(B, C), the fluorescence polarization value of the nitrobenzene aptamer probe gradually decreases with the increase of the concentration of nitrobenzene, and a good linear relationship is presented between the fluorescence polarization signal and the logarithm of the concentration of nitrobenzene; the fluorescence polarization signal generated by the DNA contrast probe has no corresponding relation with nitrobenzene, and the signal is low. Proves that the nucleic acid aptamer detection method provided by the patent can be used for quickly and effectively detecting nitrobenzene.
The above description is only an embodiment of the present invention, and the protection scope of the present invention is not limited to the above-described embodiment. All technical schemes belonging to the idea of the invention belong to the protection scope of the invention. It should be noted that modifications and embellishments within the scope of the invention may be made by those skilled in the art without departing from the principle of the invention, and such modifications and embellishments should also be considered as within the scope of the invention.
Sequence listing
<110> national institute of environmental science of south China, department of ecological environment
<120> aptamer of nitrobenzene, aptamer derivative and application thereof
<160>7
<170>SIPOSequenceListing 1.0
<210>1
<211>60
<212>DNA
<213> nucleic acid aptamer
<400>1
cacgcatagg ctcgccgtaa cacaccacac ataggtccgc tattcgcgtc cctatgcgtg 60
<210>2
<211>60
<212>DNA
<213> nucleic acid aptamer
<400>2
cacgcatagg gacgcgaata gcggacctat gtgtggtgtg ttacggcgag cctatgcgtg 60
<210>3
<211>20
<212>DNA
<213> primer
<400>3
attggcactc cacgcatagg 20
<210>4
<211>20
<212>DNA
<213> primer
<400>4
ttcacggtag cacgcatagg 20
<210>5
<211>20
<212>DNA
<213> Probe
<400>5
cctatgcgtg gagtgccaat 20
<210>6
<211>70
<212>DNA
<213> hybridization sequence
<400>6
aaaaaaaaaa cacgcatagg gacgcgaata gcggacctat gtgtggtgtg ttacggcgag 60
cctatgcgtg 70
<210>7
<211>70
<212>DNA
<213> hybridization sequence
<400>7
aaaaaaaaaa cccccccccc aaaaaacccc ccccccccca aaaaagggaa aggaaaaccc 60
ccacccccc 69

Claims (8)

1. The aptamer of nitrobenzene is characterized in that the nucleotide sequence of the aptamer is shown as SEQ ID No.1 or 2 in a sequence table.
2. The aptamer of claim 1, wherein a position on the nucleotide sequence of the aptamer is phosphorylated, oxymethylated, methylated, aminated, thiolated, fluorinated, or isotopically modified.
3. The aptamer according to claim 1, wherein the nucleotide sequence of the aptamer is labeled with biotin, digoxigenin, a fluorescent substance, a nanomaterial, polyethylene glycol, a peptide fragment, a protein, an enzyme, or folic acid.
4. An aptamer derivative of nitrobenzene, wherein said aptamer derivative is a phosphorothioate backbone derived from the backbone of the nucleotide sequence of said aptamer of claim 1, 2 or 3, or a corresponding locked nucleic acid or peptide nucleic acid modified from said aptamer of claim 1, 2 or 3.
5. Use of the aptamer according to any one of claims 1 to 3 or the aptamer derivative according to claim 4 for the detection of nitrobenzene in environments, foodstuffs and organisms.
6. Use of the aptamer according to any one of claims 1 to 3 or the aptamer derivative according to claim 4 for nitrobenzene separation and purification.
7. Use of the aptamer according to any one of claims 1 to 3 or the aptamer derivative according to claim 4 for the preparation of a nitrobenzene detection probe.
8. A nitrobenzene detection method is characterized by comprising the following steps:
a step (1) of preparing an aptamer according to any one of claims 1 to 3 or an aptamer derivative according to claim 4;
step (2), preparing a detection probe of the nitrobenzene nucleic acid aptamer;
fixing the detection probe on the surface of the SPR chip, and sealing the chip on which the detection probe is fixed by using bovine serum albumin;
and (4) carrying out nitrobenzene determination by using the chip on which the detection probe is immobilized.
CN202010777466.8A 2020-08-05 2020-08-05 Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative Active CN111876423B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010777466.8A CN111876423B (en) 2020-08-05 2020-08-05 Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010777466.8A CN111876423B (en) 2020-08-05 2020-08-05 Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative

Publications (2)

Publication Number Publication Date
CN111876423A true CN111876423A (en) 2020-11-03
CN111876423B CN111876423B (en) 2021-10-22

Family

ID=73211716

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010777466.8A Active CN111876423B (en) 2020-08-05 2020-08-05 Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative

Country Status (1)

Country Link
CN (1) CN111876423B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118562809A (en) * 2024-06-06 2024-08-30 中国海洋大学 Nucleic acid aptamers for recognizing simethoprim, terbutaline and amethoxazole and screening method
CN120505320A (en) * 2025-05-30 2025-08-19 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) Nucleic acid aptamer capable of specifically recognizing hexavalent chromium form, nucleic acid aptamer derivative and application of nucleic acid aptamer

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119752916A (en) * 2024-12-31 2025-04-04 深圳市中医院 Application of mechanical stimulation pressing targeting aptamer and derivative thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120003749A1 (en) * 2008-05-21 2012-01-05 Nec Soft, Ltd. Nucleic acid molecule capable of binding to 2,4,6-trinitrophenyl skeleton, method for detecting compound having 2,4,6-trinitrophenyl skeleton using the nucleic acid molecule, and use of the nucleic acid molecule
CN102618546A (en) * 2012-04-16 2012-08-01 中国科学院化学研究所 Aptamers capable of identifying compound containing p-nitrobenzene sulfonamide and applications of aptamers
CN108977448A (en) * 2018-08-03 2018-12-11 湖北师范大学 For detecting aptamer and its screening technique and the application of clenobuterol hydrochloride
CN110257383A (en) * 2019-06-24 2019-09-20 湖北师范大学 Nucleic acid aptamer that specifically recognizes bis(2-ethyl)hexyl phthalate, screening method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120003749A1 (en) * 2008-05-21 2012-01-05 Nec Soft, Ltd. Nucleic acid molecule capable of binding to 2,4,6-trinitrophenyl skeleton, method for detecting compound having 2,4,6-trinitrophenyl skeleton using the nucleic acid molecule, and use of the nucleic acid molecule
CN102618546A (en) * 2012-04-16 2012-08-01 中国科学院化学研究所 Aptamers capable of identifying compound containing p-nitrobenzene sulfonamide and applications of aptamers
CN108977448A (en) * 2018-08-03 2018-12-11 湖北师范大学 For detecting aptamer and its screening technique and the application of clenobuterol hydrochloride
CN110257383A (en) * 2019-06-24 2019-09-20 湖北师范大学 Nucleic acid aptamer that specifically recognizes bis(2-ethyl)hexyl phthalate, screening method and application thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHAO YAN 等: "Aptamer-mediated colorimetric method for rapid and sensitive detection of chloramphenicol in food", 《FOOD CHEMISTRY》 *
YUQI YU 等: "A novelhomogeneouslabel-freeaptasensorfor2,4,6-trinitrotoluene detection basedonanassemblystrategyofelectrochemiluminescent graphene oxidewithgoldnanoparticlesandaptamer", 《BIOSENSORS AND BIOELECTRONICS》 *
余彬彬 等: "高效液相色谱法测定地表水中硝基苯类化合物", 《环境监控与预警》 *
王勇 等: "小分子靶标的核酸适配体筛选的研究进展", 《色谱》 *
蒋谷人 等: "《临床生化检验诊断手册》", 30 June 1991 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118562809A (en) * 2024-06-06 2024-08-30 中国海洋大学 Nucleic acid aptamers for recognizing simethoprim, terbutaline and amethoxazole and screening method
CN118562809B (en) * 2024-06-06 2025-02-07 中国海洋大学 Nucleic acid aptamers for recognizing simethoprim, terbutaline and amethoxazole and screening method
CN120505320A (en) * 2025-05-30 2025-08-19 生态环境部华南环境科学研究所(生态环境部生态环境应急研究所) Nucleic acid aptamer capable of specifically recognizing hexavalent chromium form, nucleic acid aptamer derivative and application of nucleic acid aptamer

Also Published As

Publication number Publication date
CN111876423B (en) 2021-10-22

Similar Documents

Publication Publication Date Title
AU2008275917B2 (en) Multiplexed analyses of test samples
US9404919B2 (en) Multiplexed analyses of test samples
US7855054B2 (en) Multiplexed analyses of test samples
CN102703453B (en) DNA aptamer specifically recognizing streptomycin and application of DNA aptamer
CN111876423B (en) Aptamer of nitrobenzene, aptamer derivative and application of aptamer derivative
CN107446929A (en) Aptamer of specific recognition ochratoxin A and preparation method thereof
CN113215167B (en) Nucleic acid aptamers and their application in detecting largemouth bass iridovirus-infected cells
CN104630230A (en) Group of nucleic acid aptamers for specifically recognizing okadaic acid
CN111122847A (en) An aptamer-based method for rapid on-site detection of aflatoxin B1
CN114457083A (en) Single-stranded DNA (deoxyribonucleic acid) aptamer group for specifically recognizing malachite green and application thereof
CN110643611A (en) A kind of nucleic acid aptamer and its construction method and its application in detecting grouper iridovirus
CN116536322A (en) Nucleic acid aptamers, derivatives, screening methods and applications for specific recognition of new pollutant 6PPD-quinone
CN111676226B (en) Hexavalent chromium aptamer, aptamer derivative and application thereof
CN111334511B (en) Aptamer for specifically recognizing bovine pregnancy-associated glycoprotein and application thereof
CN118465253B (en) Fluorescent aptamer sensor for detecting kanamycin content and preparation method thereof
CN112961859A (en) Aptamer for specifically recognizing amantadine and application thereof
CN110564731A (en) Nucleic acid aptamer and detection kit for detection of human drug-resistant liver cancer cell line HepG2/ADM
CN114032243B (en) Nucleic acid aptamer specifically binding to ciprofloxacin and use thereof
CN116769784A (en) Nucleic acid aptamers that specifically recognize gentamicin and their screening methods and applications
CN116042630A (en) Aptamer specifically binding to S protein of porcine transmissible gastroenteritis virus and application thereof
CN112813071A (en) Aptamer sequence for specifically recognizing ribavirin and application thereof
CN115927344B (en) FAM fluorescent labeling nucleotide aptamer for detecting furacilin, sensor, kit and application
AU2017202493B2 (en) Multiplexed analyses of test samples
CN115927347B (en) Aptamer specifically binding risperidone, derivative, application and kit
CN113278621B (en) ssDNA aptamer and application thereof in identification and detection of vibrio harveyi

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Jia Wenchao

Inventor after: Xie Danping

Inventor after: Hu Kemei

Inventor after: Liu Ying

Inventor after: Liu Lijun

Inventor after: Ding Zirong

Inventor after: Fu Jianping

Inventor before: Xie Danping

Inventor before: Jia Wenchao

Inventor before: Hu Kemei

Inventor before: Liu Ying

Inventor before: Liu Lijun

Inventor before: Ding Zirong

Inventor before: Fu Jianping